AI/ML Innovations Inc. Announces Shares for Debt Transaction
AI/ML Innovations Inc. Announces Shares for Debt Transaction
VICTORIA, BC / ACCESSWIRE / June 14, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announced that it has entered into a shares for debt transaction with Wonderful Ventures LLC of Las Vegas, Nevada ("WV"). The Company entered into a finder's agreement dated June 7, 2024 with WV wherein WV would assist the Company in the search for a new CEO. Pursuant to the terms of the Finder's Agreement, the Company will pay CAD $67,600 to WV by a cash payment of $30,000 and the issuance of C$37,600 in Common Shares of the Company (the "Shares for Debt Transaction"). Pursuant to the Shares for Debt Transaction, the Company will issue an aggregate of 750,000 Common Shares, at a deemed price of $0.05 per Common Share. The proposed Shares for Debt Transaction is subject to the approval of the Canadian Securities Exchange.
2024年6月14日/ ACCESSWIRE /加拿大人工智能/机器学习创新公司(以下简称“公司”)(CSE:AIML)(OTCQB:AIMLF)(FWB:42FB)宣布已与内华达州拉斯维加斯的Wonderful Ventures LLC(以下简称“WV”)进行股份交易以弥补债务。公司与WV签订了一份于2024年6月7日的寻找新CEO的中介协议,根据发现者协议的条款,公司将通过现金支付CAD $67,600(其中$30,000为现金,C $37,600为公司普通股(“股份交易”))向WV支付。根据股份交易条款,公司将以每股$0.05的价格发行总计750,000股普通股。拟议的股份交易需经加拿大证券交易所批准。
The Common Shares issued will be subject to a four-month hold period.
发行的普通股将受到四个月的持有期限。
About AI/ML Innovations Inc.
关于人工智能/机器学习创新公司。
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".
更多关于AI/ML创新公司的信息
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
谨代表董事会
AI/ML Innovations Inc.已重新调整其业务运营以利用人工智能(AI)和机器学习(ML)的蓬勃发展,初始投资重点放在利用AI、ML、云计算和数字平台推动变革性健康管理解决方案和精准支持交付的新兴数字健康和健康公司上。通过与健康仪表盘(AIML持有95.2%的所有权)、Tech2Heal(最高持股22%,目前AIML拥有12.44%的所有权)、AI Rx Inc.(AIML持有70%的所有权)和其他计划中的增值投资进行战略合作,该公司继续利用不断扩大的增长领域,造福于公司的所有利益相关者。AI/ML的股票在加拿大证券交易所上市,代码为“AIML”,在OTCQB Venture Market上市,代码为“AIMLF”,在Frankfurt Stock Exchange上市,代码为“42FB”。
For more information about AI/ML Innovations:
执行董事Tim Daniels:
For detailed information please see AI/ML's website or the Company's filed documents at .
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
有关详细信息,请参见AI/ML的网站或公司在...的文件。
如需更多信息,请联系Blake Fallis,电话:(778)405-0882或电子邮件:info@aiml-innovations.com。
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.
本新闻稿不构成在任何司法管辖区出售或购买任何证券的要约,也不应该有任何在美国任何州出售或购买证券的要约、出售或征求。
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this release.
加拿大证券交易所及其监管服务提供商(如该术语所定义的CSE政策)概不负责本发布的充分性或准确性。
加拿大证券交易所及其监管服务提供商(如该术语所定义的CSE政策)概不负责本发布的充分性或准确性。
SOURCE: AI/ML Innovations Inc.
来源:AI/ML Innovations Inc.